Utz Brands Reports Strong Preliminary Q4 & FY25 Results with Double-Digit EBITDA Growth and Improved Leverage
Summary
Utz Brands, Inc. reported preliminary Q4 and full-year 2025 results, showing strong Adjusted EBITDA growth and positive Net Sales, with retail sales outperforming the category and an improved net leverage ratio.
Key Events
-
Strong Q4 Adjusted EBITDA Growth
The company expects Q4 2025 Adjusted EBITDA to be in the range of $62 million to $64 million, representing a significant increase of 17% to 21% compared to Q4 2024.
-
Positive Full Year 2025 Financial Performance
For the full year 2025, Utz anticipates Net Sales between $1,439 million and $1,440 million (2.4%-2.5% organic growth) and Adjusted EBITDA between $216 million and $218 million (8%-9% increase).
-
Improved Net Leverage Ratio
Utz expects to end fiscal year 2025 with a Net Leverage Ratio of approximately 3.4x, indicating progress in debt reduction and cash generation.
-
Retail Sales Outperformance
Branded Salty Snacks Retail Sales increased 3.5% in Q4 2025 and 2.9% for the full year, outperforming the overall Salty Snack Category.
Analysis
Utz Brands, Inc. announced preliminary unaudited results for the fourth quarter and full fiscal year 2025, indicating solid performance. The company achieved significant Adjusted EBITDA growth in Q4 and for the full year, alongside positive Net Sales increases. Management highlighted strong retail sales growth that outpaced the salty snack category, despite temporary inventory reductions by channel partners due to external factors like SNAP payment delays and a government shutdown. The normalization of shipment trends exiting the year, coupled with a reduced Net Leverage Ratio, suggests a positive trajectory for the company's financial health and operational efficiency. Investors should monitor the full earnings report on February 12, 2026, for detailed results and 2026 guidance.
At the time of this filing, UTZ was trading at $9.94 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $9.20 to $14.67. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.